Effects of itraconazole on cytochrome P-450-dependent sterol 14 alpha-demethylation and reduction of 3-ketosteroids in Cryptococcus neoformans
- PMID: 8257130
- PMCID: PMC192235
- DOI: 10.1128/AAC.37.10.2101
Effects of itraconazole on cytochrome P-450-dependent sterol 14 alpha-demethylation and reduction of 3-ketosteroids in Cryptococcus neoformans
Abstract
As in other pathogenic fungi, the major sterol synthesized by Cryptococcus neoformans var. neoformans is ergosterol. This yeast also shares with most pathogenic fungi a susceptibility of its cytochrome P-450-dependent ergosterol synthesis to nanomolar concentrations of itraconazole. Fifty percent inhibition of ergosterol synthesis was reached after 16 h of growth in the presence of 6.0 +/- 4.7 nM itraconazole, and complete inhibition was reached at approximately 100 nM itraconazole. This inhibition coincided with the accumulation of mainly eburicol and the 3-ketosteroid obtusifolione. The radioactivity incorporated from [14C]acetate in both compounds represents 64.2% +/- 12.9% of the radioactivity incorporated into the sterols plus squalene extracted from cells incubated in the presence of 10 nM itraconazole. The accumulation of obtusifolione as well as eburicol indicates that itraconazole inhibits not only the 14 alpha-demethylase but also (directly or indirectly) the NADPH-dependent 3-ketosteroid reductase, i.e., the enzyme catalyzing the last step in the demethylation at C-4. This latter inhibition obviates the synthesis of 4,4-demethylated 14 alpha-methylsterols that may function at least partly as surrogates of ergosterol. Eburicol and obtusifolione are unable to support cell growth, and the 3-ketosteroid has been shown to disturb membranes. The complete inhibition of ergosterol synthesis and the accumulation of the 4,4,14-trimethylsterol and of the 3-ketosteroid together with the absence of sterols, such as 14 alpha-methylfecosterol and lanosterol, which can partly fulfill some functions of ergosterol, are at the origin of the high activity of itraconazole against C. neoformans. Fifty percent inhibition of growth achieved after 16 h of incubation in the presence of 3.2 +/- 2.6 nM itraconazole.
Similar articles
-
Accumulation of 3-ketosteroids induced by itraconazole in azole-resistant clinical Candida albicans isolates.Antimicrob Agents Chemother. 1999 Nov;43(11):2663-70. doi: 10.1128/AAC.43.11.2663. Antimicrob Agents Chemother. 1999. PMID: 10543744 Free PMC article.
-
Sterol 24-C-methyltransferase: an enzymatic target for the disruption of ergosterol biosynthesis and homeostasis in Cryptococcus neoformans.Arch Biochem Biophys. 2009 Jan 15;481(2):210-8. doi: 10.1016/j.abb.2008.11.003. Epub 2008 Nov 8. Arch Biochem Biophys. 2009. PMID: 19014901
-
Perturbation of sterol biosynthesis by itraconazole and ketoconazole in Leishmania mexicana mexicana infected macrophages.Mol Biochem Parasitol. 1989 Mar 1;33(2):123-34. doi: 10.1016/0166-6851(89)90026-1. Mol Biochem Parasitol. 1989. PMID: 2542790
-
Anti-Candida drugs--the biochemical basis for their activity.Crit Rev Microbiol. 1987;15(1):57-72. doi: 10.3109/10408418709104448. Crit Rev Microbiol. 1987. PMID: 3319421 Review.
-
Biochemical targets for antifungal azole derivatives: hypothesis on the mode of action.Curr Top Med Mycol. 1985;1:313-51. doi: 10.1007/978-1-4613-9547-8_12. Curr Top Med Mycol. 1985. PMID: 3916772 Review.
Cited by
-
Therapeutic Updates on the Management of Tinea Corporis or Cruris in the Era of Trichophyton Indotineae: Separating Evidence from Hype-A Narrative Review.Indian J Dermatol. 2023 Sep-Oct;68(5):525-540. doi: 10.4103/ijd.ijd_832_23. Indian J Dermatol. 2023. PMID: 38099117 Free PMC article.
-
Antifungal resistance trends towards the year 2000. Implications for therapy and new approaches.Drugs. 1997 Nov;54(5):657-78. doi: 10.2165/00003495-199754050-00002. Drugs. 1997. PMID: 9360056 Review.
-
Revolutionising Neurological Therapeutics: Investigating Drug Repurposing Strategies.CNS Neurol Disord Drug Targets. 2025;24(2):115-131. doi: 10.2174/0118715273329531240911075309. CNS Neurol Disord Drug Targets. 2025. PMID: 39323347 Review.
-
Pharmacology of itraconazole.Drugs. 2001;61 Suppl 1:27-37. doi: 10.2165/00003495-200161001-00003. Drugs. 2001. PMID: 11219548 Review.
-
Genomic profiling of the response of Candida albicans to itraconazole treatment using a DNA microarray.Antimicrob Agents Chemother. 2001 Jun;45(6):1660-70. doi: 10.1128/AAC.45.6.1660-1670.2001. Antimicrob Agents Chemother. 2001. PMID: 11353609 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous